HCmed Innovations Co., Ltd. (TPE:6934)
Taiwan · Delayed Price · Currency is TWD 86.00
+0.70 (0.82%)
At close: Apr 24, 2026
HCmed Innovations Company Description
HCmed Innovations Co., Ltd. designs, develops, manufactures, and sells respiratory drug delivery systems in the United States, Europe, Africa, and Asia.
The company’s products include Pulmogine, a vibrating mesh nebulizer to nebulize a range of liquid medications to treat respiratory diseases and their symptoms in children and adults; and AdheResp, a breath-actuated mesh nebulizer for consumers and healthcare professionals.
It also provides intellectual property, advanced technology, customization platforms, manufacturing and commercialization, and APSD analytical services.
The company was founded in 2014 and is headquartered in Taipei, Taiwan.
HCmed Innovations Co., Ltd.
| Country | Taiwan |
| Founded | 2014 |
| Industry | Surgical and Medical Instruments and Apparatus |
| CEO | Jason Cheng |
Contact Details
Address: No. 319, Dunhua South Road Taipei, 106033 Taiwan | |
| Phone | 886 2 2732 6596 |
| Website | hcmed-inno.com |
Stock Details
| Ticker Symbol | 6934 |
| Exchange | Taiwan Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Jason Cheng | Chief Executive Officer |
| Wooca Tu | Chief Financial Officer |
| Tsai Leon | Chief Operating Officer |